Thermo Fisher Scientific sees Q2 revenue boost from COVID-19 testing

2019 11 08 00 07 5193 Thermo Fisher Amp 2019 400

Thermo Fisher Scientific saw a 10% increase in revenue in its second quarter (end-June 27).

The growth was prompted by global sales of reverse transcription polymerase chain reaction (RT-PCR) tests and other products supporting the response to the COVID-19 pandemic, according to the firm; these sales contributed more than $1.4 billion in revenue.

The company plans to release its full results for the quarter on July 22.

Page 1 of 23
Next Page